id	sid	eid	entity	type
ajlm-2268	1	1	a. kitaba	PERSON
ajlm-2268	1	2	ethiopian public health institute	ORG
ajlm-2268	1	3	addis ababa	GPE
ajlm-2268	1	4	ethiopia zelalem	GPE
ajlm-2268	1	5	t. bonger	ORG
ajlm-2268	1	6	ethiopian public health institute	ORG
ajlm-2268	1	7	addis ababa	GPE
ajlm-2268	1	8	ethiopia	GPE
ajlm-2268	1	9	ethiopian public health institute	ORG
ajlm-2268	1	10	addis ababa	GPE
ajlm-2268	1	11	ethiopia	GPE
ajlm-2268	1	12	ethiopian public health institute	ORG
ajlm-2268	1	13	addis ababa	GPE
ajlm-2268	1	14	ethiopia	GPE
ajlm-2268	1	15	tsige national clinical bacteriology	ORG
ajlm-2268	1	16	ethiopian public health institute	ORG
ajlm-2268	1	17	addis ababa	GPE
ajlm-2268	1	18	ethiopia tesfa	GPE
ajlm-2268	1	19	addis kefale	ORG
ajlm-2268	1	20	ethiopian public health institute	ORG
ajlm-2268	1	21	addis ababa	GPE
ajlm-2268	1	22	ethiopia	GPE
ajlm-2268	1	23	ethiopian public health institute	ORG
ajlm-2268	1	24	addis ababa	GPE
ajlm-2268	1	25	ethiopia dejenie s. teklu national clinical bacteriology	ORG
ajlm-2268	1	26	ethiopian public health institute	ORG
ajlm-2268	1	27	addis ababa	GPE
ajlm-2268	1	28	ethiopia elias seyoum national clinical bacteriology	ORG
ajlm-2268	1	29	ethiopian public health institute	ORG
ajlm-2268	1	30	addis ababa	GPE
ajlm-2268	1	31	ethiopia abebe a. negeri	ORG
ajlm-2268	1	32	ethiopian public health institute	ORG
ajlm-2268	1	33	addis ababa	GPE
ajlm-2268	1	34	ethiopia	GPE
ajlm-2268	1	35	kitaba	GPE
ajlm-2268	2	1	ethiopia	GPE
ajlm-2268	3	1	afr j	PERSON
ajlm-2268	4	1	2024;13(1	CARDINAL
ajlm-2268	5	1	https://doi.org/10.4102/ajlm.v13i1.2268	CARDINAL
ajlm-2268	5	2	ethiopia	GPE
ajlm-2268	5	3	a. kitaba	PERSON
ajlm-2268	5	4	degefu beyene	PERSON
ajlm-2268	5	5	zeleke ayenew	PERSON
ajlm-2268	5	6	estifanos tsige	ORG
ajlm-2268	5	7	tesfa addis kefale	PERSON
ajlm-2268	5	8	yonas mekonnen	PERSON
ajlm-2268	5	9	dejenie s. teklu	PERSON
ajlm-2268	5	10	elias seyoum	PERSON
ajlm-2268	5	11	abebe a. negeri	PERSON
ajlm-2268	5	12	17	CARDINAL
ajlm-2268	5	13	11 jan. 2024	DATE
ajlm-2268	5	14	27	CARDINAL
ajlm-2268	6	1	2024	CARDINAL
ajlm-2268	6	2	2024	DATE
ajlm-2268	11	1	5-year	DATE
ajlm-2268	12	1	2017	CARDINAL
ajlm-2268	12	2	2021	CARDINAL
ajlm-2268	12	3	ethiopian	NORP
ajlm-2268	13	1	bd phoenix m50	ORG
ajlm-2268	14	1	bd phoenix m50	ORG
ajlm-2268	15	1	cochran armitage	ORG
ajlm-2268	16	1	less than 0.05	CARDINAL
ajlm-2268	17	1	5382	CARDINAL
ajlm-2268	17	2	458	CARDINAL
ajlm-2268	17	3	9%	PERCENT
ajlm-2268	17	4	e. coli	PERSON
ajlm-2268	17	5	266	CARDINAL
ajlm-2268	17	6	5%	PERCENT
ajlm-2268	17	7	k. pneumoniae	PERSON
ajlm-2268	18	1	k. pneumoniae	PERSON
ajlm-2268	18	2	88%	PERCENT
ajlm-2268	18	3	e. coli	PERSON
ajlm-2268	18	4	65%	PERCENT
ajlm-2268	19	1	k. pneumoniae	PERSON
ajlm-2268	19	2	14%	PERCENT
ajlm-2268	19	3	e. coli	PERSON
ajlm-2268	19	4	5%	PERCENT
ajlm-2268	20	1	k. pneumoniae	PERSON
ajlm-2268	20	2	0% to 38%	PERCENT
ajlm-2268	20	3	0.001	CARDINAL
ajlm-2268	20	4	41% to 90%	PERCENT
ajlm-2268	20	5	0.001	CARDINAL
ajlm-2268	20	6	between 2017 and 2021	CARDINAL
ajlm-2268	22	1	k. pneumoniae	PERSON
ajlm-2268	22	2	carbapenem	PERSON
ajlm-2268	24	1	ethiopian public health institute	ORG
ajlm-2268	24	2	ethiopia	GPE
ajlm-2268	25	1	e. coli	PERSON
ajlm-2268	25	2	k. pneumoniae	PERSON
ajlm-2268	25	3	k. pneumoniae	PERSON
ajlm-2268	25	4	e. coli	PERSON
ajlm-2268	25	5	25%	PERCENT
ajlm-2268	25	6	european	NORP
ajlm-2268	25	7	e. coli	PERSON
ajlm-2268	25	8	k. pneumoniae	PERSON
ajlm-2268	25	9	the united states	GPE
ajlm-2268	25	10	e. coli	PERSON
ajlm-2268	25	11	k. pneumoniae	PERSON
ajlm-2268	25	12	k. pneumoniae	PERSON
ajlm-2268	25	13	the world health organization classified	ORG
ajlm-2268	25	14	e. coli	PERSON
ajlm-2268	26	1	k. pneumoniae.8,9,10,11,12,13	PERSON
ajlm-2268	26	2	10-year	DATE
ajlm-2268	26	3	china	GPE
ajlm-2268	26	4	6.7%	PERCENT
ajlm-2268	26	5	2010	DATE
ajlm-2268	26	6	56.7%	PERCENT
ajlm-2268	26	7	2019.12	CARDINAL
ajlm-2268	26	8	malawi	GPE
ajlm-2268	26	9	e. coli	PERSON
ajlm-2268	26	10	0.0%	PERCENT
ajlm-2268	26	11	1998	DATE
ajlm-2268	26	12	31.1%	PERCENT
ajlm-2268	26	13	2016	DATE
ajlm-2268	26	14	1.7%	PERCENT
ajlm-2268	26	15	1998	DATE
ajlm-2268	26	16	70.2%	PERCENT
ajlm-2268	26	17	2016).14	CARDINAL
ajlm-2268	26	18	africa	LOC
ajlm-2268	26	19	african	NORP
ajlm-2268	26	20	african	NORP
ajlm-2268	26	21	ethiopia	GPE
ajlm-2268	26	22	e. coli	PERSON
ajlm-2268	26	23	ethiopia	GPE
ajlm-2268	27	1	5-year	DATE
ajlm-2268	27	2	e. coli	PERSON
ajlm-2268	27	3	k. pneumoniae	PERSON
ajlm-2268	27	4	ethiopian	NORP
ajlm-2268	28	1	e. coli	PERSON
ajlm-2268	28	2	k. pneumoniae	PERSON
ajlm-2268	31	1	the institutional review board	ORG
ajlm-2268	31	2	ethiopian	NORP
ajlm-2268	33	1	helsinki	PERSON
ajlm-2268	33	2	2013	DATE
ajlm-2268	34	1	e. coli	PERSON
ajlm-2268	34	2	ethiopian	NORP
ajlm-2268	34	3	between january 2017	DATE
ajlm-2268	34	4	december 2021	DATE
ajlm-2268	36	1	ethiopian	NORP
ajlm-2268	36	2	15189:2012	CARDINAL
ajlm-2268	36	3	35 °	QUANTITY
ajlm-2268	36	4	37 °	QUANTITY
ajlm-2268	37	1	vitek 2	PERSON
ajlm-2268	37	2	biomérieux	ORG
ajlm-2268	37	3	france	GPE
ajlm-2268	37	4	bd phoenix m50	PERSON
ajlm-2268	37	5	becton, dickinson and company	ORG
ajlm-2268	37	6	franklin lakes	ORG
ajlm-2268	37	7	new jersey	GPE
ajlm-2268	37	8	united states	GPE
ajlm-2268	38	1	gram	CARDINAL
ajlm-2268	38	2	oxoid ltd.	ORG
ajlm-2268	38	3	basingstoke	GPE
ajlm-2268	38	4	hampshire	GPE
ajlm-2268	38	5	england	GPE
ajlm-2268	38	6	biomark	GPE
ajlm-2268	38	7	pune	GPE
ajlm-2268	38	8	maharashtra	GPE
ajlm-2268	38	9	india	GPE
ajlm-2268	38	10	mumbai	GPE
ajlm-2268	38	11	maharashtra	GPE
ajlm-2268	38	12	india	GPE
ajlm-2268	38	13	simmons citrate	ORG
ajlm-2268	38	14	biomark	GPE
ajlm-2268	38	15	pune	GPE
ajlm-2268	38	16	maharashtra	GPE
ajlm-2268	38	17	india	GPE
ajlm-2268	38	18	himedia	GPE
ajlm-2268	38	19	mumbai	GPE
ajlm-2268	38	20	maharashtra	GPE
ajlm-2268	38	21	india	GPE
ajlm-2268	38	22	degli abruzzi	PERSON
ajlm-2268	38	23	italy	GPE
ajlm-2268	39	1	muller hinton	ORG
ajlm-2268	39	2	oxoid ltd.	ORG
ajlm-2268	39	3	basingstoke	GPE
ajlm-2268	39	4	hampshire	GPE
ajlm-2268	39	5	england	GPE
ajlm-2268	39	6	bd phoenix m50 system	ORG
ajlm-2268	40	1	m100	PRODUCT
ajlm-2268	40	2	american	NORP
ajlm-2268	41	1	e. coli american	PERSON
ajlm-2268	41	2	25922	DATE
ajlm-2268	41	3	american	NORP
ajlm-2268	41	4	25923	DATE
ajlm-2268	41	5	american	NORP
ajlm-2268	41	6	27853	DATE
ajlm-2268	42	1	second	ORDINAL
ajlm-2268	43	1	at least one	CARDINAL
ajlm-2268	44	1	at least one	CARDINAL
ajlm-2268	44	2	ceftazidime	PERSON
ajlm-2268	45	1	at least one	CARDINAL
ajlm-2268	47	1	carbapenem resistance	PERSON
ajlm-2268	47	2	meropenem	GPE
ajlm-2268	47	3	imipenem	GPE
ajlm-2268	48	1	cefazolin	GPE
ajlm-2268	48	2	second	ORDINAL
ajlm-2268	51	1	first	ORDINAL
ajlm-2268	53	1	each year	DATE
ajlm-2268	53	2	the 5 years	DATE
ajlm-2268	55	1	cochran armitage	ORG
ajlm-2268	56	1	less than 0.05	CARDINAL
ajlm-2268	57	1	7199	CARDINAL
ajlm-2268	57	2	2017	CARDINAL
ajlm-2268	57	3	2021	CARDINAL
ajlm-2268	57	4	1	CARDINAL
ajlm-2268	58	1	nasal swabs	ORG
ajlm-2268	60	1	5382	CARDINAL
ajlm-2268	60	2	458	CARDINAL
ajlm-2268	60	3	9%	PERCENT
ajlm-2268	60	4	e. coli	PERSON
ajlm-2268	60	5	266	CARDINAL
ajlm-2268	60	6	5%	PERCENT
ajlm-2268	63	1	k. pneumoniae	PERSON
ajlm-2268	63	2	13%	PERCENT
ajlm-2268	64	1	1	CARDINAL
ajlm-2268	65	1	ethiopian public health institute	ORG
ajlm-2268	65	2	addis ababa	GPE
ajlm-2268	65	3	ethiopia	GPE
ajlm-2268	65	4	january 2017	DATE
ajlm-2268	65	5	december 2021	DATE
ajlm-2268	66	1	e. coli	PERSON
ajlm-2268	66	2	k. pneumoniae	PERSON
ajlm-2268	66	3	2890	CARDINAL
ajlm-2268	66	4	54%	PERCENT
ajlm-2268	66	5	46%	PERCENT
ajlm-2268	66	6	1	CARDINAL
ajlm-2268	67	1	46%	PERCENT
ajlm-2268	67	2	between 19 and 45 years	DATE
ajlm-2268	68	1	5382	DATE
ajlm-2268	68	2	42%	PERCENT
ajlm-2268	68	3	40%	PERCENT
ajlm-2268	68	4	18%	PERCENT
ajlm-2268	69	1	724	CARDINAL
ajlm-2268	69	2	458	CARDINAL
ajlm-2268	69	3	63%	PERCENT
ajlm-2268	69	4	e. coli	PERSON
ajlm-2268	69	5	356	CARDINAL
ajlm-2268	69	6	78%	PERCENT
ajlm-2268	70	1	266	CARDINAL
ajlm-2268	70	2	37%	PERCENT
ajlm-2268	70	3	k. pneumoniae	PERSON
ajlm-2268	70	4	129 (	PERCENT
ajlm-2268	70	5	50%	PERCENT
ajlm-2268	71	1	about 82%	PERCENT
ajlm-2268	72	1	e. coli	PERSON
ajlm-2268	72	2	261	CARDINAL
ajlm-2268	72	3	57%	PERCENT
ajlm-2268	72	4	k. pneumoniae	PERSON
ajlm-2268	72	5	58%	PERCENT
ajlm-2268	73	1	1	CARDINAL
ajlm-2268	74	1	ethiopian	NORP
ajlm-2268	74	2	addis ababa	GPE
ajlm-2268	74	3	ethiopia	GPE
ajlm-2268	74	4	january 2017	DATE
ajlm-2268	74	5	december 2021	DATE
ajlm-2268	75	1	five-year	DATE
ajlm-2268	75	2	e. coli	PERSON
ajlm-2268	75	3	88%	PERCENT
ajlm-2268	75	4	piperacillin	ORG
ajlm-2268	75	5	84%	PERCENT
ajlm-2268	75	6	80%	PERCENT
ajlm-2268	75	7	2%	PERCENT
ajlm-2268	75	8	meropenem	GPE
ajlm-2268	75	9	3%	PERCENT
ajlm-2268	75	10	imipenem	GPE
ajlm-2268	75	11	5%	PERCENT
ajlm-2268	75	12	2	CARDINAL
ajlm-2268	76	1	cefazolin	GPE
ajlm-2268	76	2	91%	PERCENT
ajlm-2268	76	3	cefuroxime	GPE
ajlm-2268	76	4	91%	PERCENT
ajlm-2268	76	5	ceftriaxone	GPE
ajlm-2268	76	6	92%	PERCENT
ajlm-2268	76	7	97%	PERCENT
ajlm-2268	76	8	9%	PERCENT
ajlm-2268	76	9	13%	PERCENT
ajlm-2268	76	10	meropenem	GPE
ajlm-2268	76	11	13%	PERCENT
ajlm-2268	76	12	imipenem	GPE
ajlm-2268	76	13	17%	PERCENT
ajlm-2268	77	1	2	CARDINAL
ajlm-2268	77	2	ethiopian	NORP
ajlm-2268	77	3	addis ababa	GPE
ajlm-2268	77	4	ethiopia	GPE
ajlm-2268	77	5	january 2017	DATE
ajlm-2268	77	6	december 2021	DATE
ajlm-2268	78	1	3	CARDINAL
ajlm-2268	79	1	60% to 82%	PERCENT
ajlm-2268	79	2	71% to 80%	PERCENT
ajlm-2268	79	3	between 2017	CARDINAL
ajlm-2268	79	4	2021	DATE
ajlm-2268	80	1	e. coli	PERSON
ajlm-2268	80	2	70%	PERCENT
ajlm-2268	80	3	2017	DATE
ajlm-2268	80	4	68%	PERCENT
ajlm-2268	80	5	2018	DATE
ajlm-2268	80	6	60%	PERCENT
ajlm-2268	80	7	2019	DATE
ajlm-2268	80	8	72%	PERCENT
ajlm-2268	80	9	2020	DATE
ajlm-2268	80	10	80%	PERCENT
ajlm-2268	80	11	2021	CARDINAL
ajlm-2268	81	1	3	CARDINAL
ajlm-2268	81	2	ethiopian	NORP
ajlm-2268	81	3	addis ababa	GPE
ajlm-2268	81	4	ethiopia	GPE
ajlm-2268	81	5	january 2017	DATE
ajlm-2268	81	6	december 2021	DATE
ajlm-2268	82	1	carbapenem	PERSON
ajlm-2268	83	1	2017	DATE
ajlm-2268	83	2	e. coli	PERSON
ajlm-2268	83	3	4%	PERCENT
ajlm-2268	84	1	10%	PERCENT
ajlm-2268	84	2	2018	DATE
ajlm-2268	84	3	2%	PERCENT
ajlm-2268	84	4	2019	DATE
ajlm-2268	84	5	0%	PERCENT
ajlm-2268	84	6	2020	DATE
ajlm-2268	84	7	9%	PERCENT
ajlm-2268	84	8	2021	DATE
ajlm-2268	85	1	57%	PERCENT
ajlm-2268	85	2	71%	PERCENT
ajlm-2268	85	3	second	ORDINAL
ajlm-2268	85	4	54%	PERCENT
ajlm-2268	85	5	72%	PERCENT
ajlm-2268	86	1	2017	DATE
ajlm-2268	86	2	e. coli	PERSON
ajlm-2268	86	3	71%	PERCENT
ajlm-2268	87	1	65%	PERCENT
ajlm-2268	87	2	2018	DATE
ajlm-2268	87	3	63%	PERCENT
ajlm-2268	87	4	2019	DATE
ajlm-2268	87	5	57%	PERCENT
ajlm-2268	87	6	2020	DATE
ajlm-2268	87	7	69%	PERCENT
ajlm-2268	87	8	2021	DATE
ajlm-2268	88	1	23% to 31%	PERCENT
ajlm-2268	88	2	between 2017 and 2021	CARDINAL
ajlm-2268	88	3	41% to 20%	PERCENT
ajlm-2268	89	1	k. pneumoniae	PERSON
ajlm-2268	89	2	88%	PERCENT
ajlm-2268	89	3	51%	PERCENT
ajlm-2268	89	4	44%	PERCENT
ajlm-2268	89	5	14%	PERCENT
ajlm-2268	89	6	4	CARDINAL
ajlm-2268	90	1	0.0001	CARDINAL
ajlm-2268	91	1	the 5 years	DATE
ajlm-2268	91	2	0%	PERCENT
ajlm-2268	91	3	2017	DATE
ajlm-2268	91	4	8%	PERCENT
ajlm-2268	91	5	2018	DATE
ajlm-2268	91	6	2019	DATE
ajlm-2268	91	7	19%	PERCENT
ajlm-2268	91	8	2020	DATE
ajlm-2268	91	9	39%	PERCENT
ajlm-2268	91	10	2021	CARDINAL
ajlm-2268	91	11	0.001	CARDINAL
ajlm-2268	92	1	2017 to 2018	DATE
ajlm-2268	92	2	k. pneumoniae	PERSON
ajlm-2268	92	3	41% to 24%	PERCENT
ajlm-2268	93	1	2019	DATE
ajlm-2268	93	2	39%	PERCENT
ajlm-2268	93	3	71%	PERCENT
ajlm-2268	93	4	2020	DATE
ajlm-2268	93	5	90%	PERCENT
ajlm-2268	93	6	2021	CARDINAL
ajlm-2268	93	7	0.001	CARDINAL
ajlm-2268	94	1	the first 3 years	DATE
ajlm-2268	94	2	between 81% and 85%	PERCENT
ajlm-2268	95	1	100%	PERCENT
ajlm-2268	95	2	2020	DATE
ajlm-2268	95	3	91%	PERCENT
ajlm-2268	95	4	2021	CARDINAL
ajlm-2268	96	1	4	CARDINAL
ajlm-2268	96	2	ethiopian	NORP
ajlm-2268	96	3	addis ababa	GPE
ajlm-2268	96	4	ethiopia	GPE
ajlm-2268	96	5	january 2017	DATE
ajlm-2268	96	6	december 2021	DATE
ajlm-2268	97	1	above 80%	PERCENT
ajlm-2268	98	1	2017	DATE
ajlm-2268	98	2	57%	PERCENT
ajlm-2268	99	1	46%	PERCENT
ajlm-2268	99	2	2018	DATE
ajlm-2268	99	3	42%	PERCENT
ajlm-2268	99	4	2019	DATE
ajlm-2268	99	5	71%	PERCENT
ajlm-2268	99	6	2020	DATE
ajlm-2268	99	7	67%	PERCENT
ajlm-2268	99	8	2021	DATE
ajlm-2268	100	1	33% to 79%	PERCENT
ajlm-2268	100	2	between 2017 and 2021	CARDINAL
ajlm-2268	101	1	the first 2 years	DATE
ajlm-2268	101	2	50% to 79%	PERCENT
ajlm-2268	101	3	54%	PERCENT
ajlm-2268	101	4	2019	DATE
ajlm-2268	102	1	2020	DATE
ajlm-2268	102	2	2021	DATE
ajlm-2268	102	3	below 50%	PERCENT
ajlm-2268	102	4	33%	PERCENT
ajlm-2268	102	5	2020	DATE
ajlm-2268	102	6	42%	PERCENT
ajlm-2268	102	7	2021	DATE
ajlm-2268	103	1	piperacillin	ORG
ajlm-2268	104	1	k. pneumoniae	PERSON
ajlm-2268	104	2	cefazolin	GPE
ajlm-2268	104	3	cefuroxime	GPE
ajlm-2268	104	4	ceftriaxone	GPE
ajlm-2268	104	5	piperacillin	ORG
ajlm-2268	104	6	meropenem	GPE
ajlm-2268	105	1	5 years	DATE
ajlm-2268	106	1	carbapenem	PERSON
ajlm-2268	107	1	ethiopian	NORP
ajlm-2268	108	1	cefuroxime	GPE
ajlm-2268	108	2	ceftriaxone	GPE
ajlm-2268	108	3	cefazolin	GPE
ajlm-2268	108	4	cefuroxime	GPE
ajlm-2268	109	1	ethiopian	NORP
ajlm-2268	109	2	2021	CARDINAL
ajlm-2268	109	3	ethiopia	GPE
ajlm-2268	109	4	norfloxacin	ORG
ajlm-2268	109	5	ambo university referral hospital	ORG
ajlm-2268	109	6	ethiopia	GPE
ajlm-2268	109	7	2019	DATE
ajlm-2268	109	8	21.7%	PERCENT
ajlm-2268	109	9	50.7%	PERCENT
ajlm-2268	110	1	36.4%	PERCENT
ajlm-2268	111	1	four	CARDINAL
ajlm-2268	111	2	ethiopia	GPE
ajlm-2268	111	3	2017	CARDINAL
ajlm-2268	111	4	amoxicillin	GPE
ajlm-2268	111	5	ceftriaxone	GPE
ajlm-2268	111	6	three	CARDINAL
ajlm-2268	111	7	addis ababa	GPE
ajlm-2268	111	8	ethiopia	GPE
ajlm-2268	111	9	2016	DATE
ajlm-2268	111	10	44.8%	PERCENT
ajlm-2268	111	11	13.6%	PERCENT
ajlm-2268	111	12	11.2%.28	CARDINAL
ajlm-2268	112	1	ethiopian	NORP
ajlm-2268	113	1	k. pneumoniae	PERSON
ajlm-2268	113	2	38%	PERCENT
ajlm-2268	113	3	the end of 2021	DATE
ajlm-2268	114	1	china	GPE
ajlm-2268	114	2	meropenem	GPE
ajlm-2268	114	3	k. pneumoniae	PERSON
ajlm-2268	114	4	2.9%	PERCENT
ajlm-2268	114	5	2005	DATE
ajlm-2268	114	6	26.3%	PERCENT
ajlm-2268	114	7	2018	DATE
ajlm-2268	114	8	20-year	DATE
ajlm-2268	114	9	1997–2016	CARDINAL
ajlm-2268	114	10	k. pneumoniae	PERSON
ajlm-2268	114	11	0.7%	PERCENT
ajlm-2268	114	12	1997	DATE
ajlm-2268	114	13	14.2%	PERCENT
ajlm-2268	114	14	2016	DATE
ajlm-2268	114	15	europe	LOC
ajlm-2268	114	16	0.001).30	CARDINAL
ajlm-2268	114	17	14	CARDINAL
ajlm-2268	114	18	new york city	GPE
ajlm-2268	114	19	k. pneumoniae	PERSON
ajlm-2268	114	20	6	CARDINAL
ajlm-2268	114	21	14	CARDINAL
ajlm-2268	114	22	k. pneumoniae	PERSON
ajlm-2268	114	23	38%	PERCENT
ajlm-2268	114	24	2006	DATE
ajlm-2268	114	25	29%	PERCENT
ajlm-2268	114	26	2009	DATE
ajlm-2268	114	27	the united states	GPE
ajlm-2268	114	28	new york	GPE
ajlm-2268	114	29	united states	GPE
ajlm-2268	114	30	2016 to 2020	DATE
ajlm-2268	114	31	january 2021	DATE
ajlm-2268	114	32	2022.33	CARDINAL
ajlm-2268	114	33	new york	GPE
ajlm-2268	114	34	k. pneumoniae	PERSON
ajlm-2268	114	35	2017	DATE
ajlm-2268	114	36	41%	PERCENT
ajlm-2268	114	37	2021	CARDINAL
ajlm-2268	114	38	90%	PERCENT
ajlm-2268	114	39	sichuan	GPE
ajlm-2268	114	40	china	GPE
ajlm-2268	114	41	2017 to 2020	DATE
ajlm-2268	114	42	14.7%	PERCENT
ajlm-2268	114	43	2017	DATE
ajlm-2268	114	44	26.5%	PERCENT
ajlm-2268	114	45	2020.34	CARDINAL
ajlm-2268	114	46	7.3%	PERCENT
ajlm-2268	114	47	1997	DATE
ajlm-2268	114	48	27.9%	PERCENT
ajlm-2268	114	49	2016	DATE
ajlm-2268	114	50	taiwan	GPE
ajlm-2268	114	51	2002–2012)35	GPE
ajlm-2268	114	52	89.9%	PERCENT
ajlm-2268	114	53	2002 to 2006	DATE
ajlm-2268	114	54	81.6%	PERCENT
ajlm-2268	114	55	2008 to 2012	DATE
ajlm-2268	115	1	korean	NORP
ajlm-2268	115	2	k. pneumoniae	PERSON
ajlm-2268	115	3	2013	DATE
ajlm-2268	115	4	2015.13	CARDINAL
ajlm-2268	116	1	first	ORDINAL
ajlm-2268	116	2	e. coli	PERSON
ajlm-2268	116	3	k. pneumoniae	PERSON
ajlm-2268	117	1	75%	PERCENT
ajlm-2268	117	2	k. pneumoniae 85%	PERSON
ajlm-2268	117	3	69%	PERCENT
ajlm-2268	117	4	k. pneumoniae 44%	PERSON
ajlm-2268	117	5	first	ORDINAL
ajlm-2268	117	6	fourth	ORDINAL
ajlm-2268	117	7	65%	PERCENT
ajlm-2268	117	8	k. pneumoniae 88%	PERSON
ajlm-2268	117	9	28%	PERCENT
ajlm-2268	117	10	k. pneumoniae 51%	PERSON
ajlm-2268	117	11	5-year	DATE
ajlm-2268	118	1	kenya,36	PERSON
ajlm-2268	118	2	e. coli	PERSON
ajlm-2268	118	3	k. pneumoniae	PERSON
ajlm-2268	121	1	switzerland	GPE
ajlm-2268	121	2	8 years	DATE
ajlm-2268	121	3	2009–2016	CARDINAL
ajlm-2268	121	4	k. pneumoniae	PERSON
ajlm-2268	121	5	fourth	ORDINAL
ajlm-2268	121	6	6%	PERCENT
ajlm-2268	122	1	5%	PERCENT
ajlm-2268	122	2	14%	PERCENT
ajlm-2268	123	1	12%	PERCENT
ajlm-2268	123	2	23%	PERCENT
ajlm-2268	124	1	11%).43	CARDINAL
ajlm-2268	127	1	k. pneumoniae	PERSON
ajlm-2268	127	2	first	ORDINAL
ajlm-2268	127	3	ethiopian	NORP
ajlm-2268	129	1	k. pneumoniae	PERSON
ajlm-2268	133	1	ethiopian	NORP
ajlm-2268	134	1	mulushewa g	PERSON
ajlm-2268	139	1	d.b.	PERSON
ajlm-2268	139	2	z.a.	GPE
ajlm-2268	139	3	e.t.	PERSON
ajlm-2268	139	4	d.s.t.	GPE
ajlm-2268	139	5	y.m.	GPE
ajlm-2268	144	1	ethiopian	NORP
ajlm-2268	148	1	paterson dl	PERSON
ajlm-2268	148	2	gram	CARDINAL
ajlm-2268	149	1	2006;34(5	CARDINAL
ajlm-2268	149	2	suppl.):20–28	GPE
ajlm-2268	154	1	2019	DATE
ajlm-2268	154	2	1–4	CARDINAL
ajlm-2268	155	1	2023	CARDINAL
ajlm-2268	155	2	february 25	DATE
ajlm-2268	156	1	https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis	GPE
ajlm-2268	157	1	the united states	GPE
ajlm-2268	157	2	2019	DATE
ajlm-2268	158	1	atlanta	GPE
ajlm-2268	158	2	ga	ORG
ajlm-2268	158	3	cdc	ORG
ajlm-2268	158	4	2019	DATE
ajlm-2268	159	1	shaikh s	PERSON
ajlm-2268	159	2	fatima j	PERSON
ajlm-2268	159	3	rizvi smd	PERSON
ajlm-2268	159	4	kamal ma	PERSON
ajlm-2268	161	1	saudi	NORP
ajlm-2268	161	2	biol sci	PERSON
ajlm-2268	162	1	2015;22(1):90–101	CARDINAL
ajlm-2268	163	1	sader hs	PERSON
ajlm-2268	163	2	farrell	PERSON
ajlm-2268	163	3	flamm rk	PERSON
ajlm-2268	163	4	jones rn	PERSON
ajlm-2268	163	5	gram	CARDINAL
ajlm-2268	163	6	us	GPE
ajlm-2268	163	7	european	NORP
ajlm-2268	163	8	2009–2012	CARDINAL
ajlm-2268	164	1	j antimicrob	PERSON
ajlm-2268	165	1	2014;43(4):328–334	CARDINAL
ajlm-2268	165	2	rosenthal vd	PERSON
ajlm-2268	165	3	bijie h	PERSON
ajlm-2268	165	4	mehta y	PERSON
ajlm-2268	165	5	36	CARDINAL
ajlm-2268	165	6	2004–2009	DATE
ajlm-2268	166	1	2012;40(5):396–407	CARDINAL
ajlm-2268	166	2	eu	ORG
ajlm-2268	166	3	2012	DATE
ajlm-2268	167	1	bitaw	GPE
ajlm-2268	167	2	evans m. multidrug-resistant	PERSON
ajlm-2268	167	3	gram	CARDINAL
ajlm-2268	168	1	plos	PERSON
ajlm-2268	168	2	one	CARDINAL
ajlm-2268	169	1	2019;14(9):e0222911	CARDINAL
ajlm-2268	170	1	https://doi.org/10.1371/journal.pone.0222911 javaid n	PERSON
ajlm-2268	170	2	rasool k	PERSON
ajlm-2268	170	3	pakistan	GPE
ajlm-2268	170	4	2011–2015	DATE
ajlm-2268	171	1	plos one.	ORG
ajlm-2268	172	1	2021;16(4):e0250226	CARDINAL
ajlm-2268	173	1	zellweger rm	PERSON
ajlm-2268	175	1	kathmandu	GPE
ajlm-2268	175	2	23-year	DATE
ajlm-2268	177	1	2018;5(sep):1–8	CARDINAL
ajlm-2268	178	1	carroll m	PERSON
ajlm-2268	178	2	five-year	DATE
ajlm-2268	178	3	kigali	GPE
ajlm-2268	178	4	rwanda	GPE
ajlm-2268	179	1	j trop med	PERSON
ajlm-2268	180	1	https://doi.org/10.4269/ajtmh.16-0392 liu c	PERSON
ajlm-2268	180	2	xu m	PERSON
ajlm-2268	180	3	li x	PERSON
ajlm-2268	180	4	dong h	ORG
ajlm-2268	180	5	ming l.	PERSON
ajlm-2268	180	6	china	GPE
ajlm-2268	180	7	10-year	DATE
ajlm-2268	180	8	2010–2019	CARDINAL
ajlm-2268	181	1	j glob	PERSON
ajlm-2268	182	1	2022;29:413–419	CARDINAL
ajlm-2268	183	1	ahn jy	PERSON
ajlm-2268	183	2	lee ch	PERSON
ajlm-2268	184	1	gram	CARDINAL
ajlm-2268	184	2	korean	NORP
ajlm-2268	186	1	2017;37(3):231–239	CARDINAL
ajlm-2268	188	1	cornick je	PERSON
ajlm-2268	188	2	malawi	GPE
ajlm-2268	188	3	1998–2016	DATE
ajlm-2268	189	1	lancet	ORG
ajlm-2268	191	1	https://doi.org/10.1016/s1473-3099(17)30394-8 massongo m	PERSON
ajlm-2268	191	2	ngando l	ORG
ajlm-2268	191	3	pefura yone ew	PERSON
ajlm-2268	191	4	cameroon	GPE
ajlm-2268	191	5	between 2010 and 2017	DATE
ajlm-2268	193	1	2021;2021:9957112	CARDINAL
ajlm-2268	194	1	harare	GPE
ajlm-2268	194	2	zimbabwe	GPE
ajlm-2268	194	3	2012–2017	CARDINAL
ajlm-2268	195	1	bmc infect dis	ORG
ajlm-2268	196	1	2019;19(1):1–9	ORG
ajlm-2268	197	1	negeri aa	PERSON
ajlm-2268	197	2	legese	NORP
ajlm-2268	197	3	bedada tl	ORG
ajlm-2268	197	4	woldemariam hk	PERSON
ajlm-2268	197	5	tullu kd	PERSON
ajlm-2268	197	6	addis	GPE
ajlm-2268	198	1	antimicrob	PERSON
ajlm-2268	200	1	gram	CARDINAL
ajlm-2268	200	2	ethiopia	GPE
ajlm-2268	201	1	antimicrob	PERSON
ajlm-2268	202	1	2022;11(1):1–12	CARDINAL
ajlm-2268	203	1	africa	LOC
ajlm-2268	206	1	2022	CARDINAL
ajlm-2268	206	2	aug 20	DATE
ajlm-2268	207	1	1–14	CARDINAL
ajlm-2268	210	1	29th	TIME
ajlm-2268	210	2	clsi	PERSON
ajlm-2268	210	3	m100	PRODUCT
ajlm-2268	210	4	wayne	PERSON
ajlm-2268	212	1	2019	DATE
ajlm-2268	212	2	clsi	PERSON
ajlm-2268	214	1	13th	ORDINAL
ajlm-2268	214	2	clsi standard m02	PERSON
ajlm-2268	215	1	wayne	PERSON
ajlm-2268	215	2	2018	DATE
ajlm-2268	219	1	geneva	GPE
ajlm-2268	219	2	2021	DATE
ajlm-2268	219	3	2023 nov 25	DATE
ajlm-2268	223	1	vienna	GPE
ajlm-2268	223	2	2021	CARDINAL
ajlm-2268	223	3	2023 nov 26	DATE
ajlm-2268	226	1	3rd	ORDINAL
ajlm-2268	227	1	2014	DATE
ajlm-2268	228	1	addis ababa	GPE
ajlm-2268	228	2	fmhaca	PERSON
ajlm-2268	229	1	kano z. antibiotics	PERSON
ajlm-2268	229	2	ethiopia	GPE
ajlm-2268	231	1	2023;16(1):1–9	CARDINAL
ajlm-2268	232	1	mekonnen eticha e	PERSON
ajlm-2268	232	2	gemechu wd	ORG
ajlm-2268	233	1	ambo university referral hospital	ORG
ajlm-2268	235	1	2021;15:467–473	CARDINAL
ajlm-2268	236	1	amare	ORG
ajlm-2268	236	2	tesfa	GPE
ajlm-2268	236	3	baye y. hospital	PERSON
ajlm-2268	236	4	ethiopia	GPE
ajlm-2268	240	1	https://doi.org/10.2147/ijgm.s280696 worku	PERSON
ajlm-2268	240	2	d.	NORP
ajlm-2268	240	3	addis ababa	GPE
ajlm-2268	240	4	ethiopia	GPE
ajlm-2268	241	1	interdiscip perspect	ORG
ajlm-2268	242	1	4323769	CARDINAL
ajlm-2268	243	1	https://doi.org/10.1155/2018/4323769 hu	PERSON
ajlm-2268	244	1	guo y	PERSON
ajlm-2268	244	2	yang y	PERSON
ajlm-2268	245	1	china	GPE
ajlm-2268	245	2	2018	DATE
ajlm-2268	246	1	eur	CARDINAL
ajlm-2268	246	2	j clin microbiol	PERSON
ajlm-2268	248	1	https://doi.org/10.1007/s10096-019-03673-1 sader hs	PERSON
ajlm-2268	248	2	castanheira m	PERSON
ajlm-2268	248	3	arends sjr	PERSON
ajlm-2268	248	4	goossens h	PERSON
ajlm-2268	249	1	20 years	DATE
ajlm-2268	249	2	1997–2016	CARDINAL
ajlm-2268	250	1	j antimicrob	PERSON
ajlm-2268	251	1	2019;74(6):1595–1606	CARDINAL
ajlm-2268	252	1	ayukekbong ja	PERSON
ajlm-2268	252	2	ntemgwa m	PERSON
ajlm-2268	254	1	antimicrob	PERSON
ajlm-2268	255	1	babu e	PERSON
ajlm-2268	256	1	new york city	GPE
ajlm-2268	257	1	j antimicrob	PERSON
ajlm-2268	258	1	2012;67(6):1427–1431	CARDINAL
ajlm-2268	259	1	https://doi.org/10.1093/jac/dks063 lee j	PERSON
ajlm-2268	259	2	nazarian e	PERSON
ajlm-2268	259	3	carbapenem	PERSON
ajlm-2268	259	4	new york	GPE
ajlm-2268	259	5	new york	GPE
ajlm-2268	259	6	usa	GPE
ajlm-2268	259	7	2016–2022	CARDINAL
ajlm-2268	262	1	https://doi.org/10.3201/eid2910.230153 zhang j	PERSON
ajlm-2268	262	2	huang x	PERSON
ajlm-2268	262	3	sichuan	GPE
ajlm-2268	262	4	china	GPE
ajlm-2268	262	5	2017 to 2020	DATE
ajlm-2268	265	1	https://doi.org/10.3389/fmed.2022.759214 lin	PERSON
ajlm-2268	265	2	wang jt	PERSON
ajlm-2268	265	3	chang sc	PERSON
ajlm-2268	266	1	taiwan	GPE
ajlm-2268	267	1	sci rep	ORG
ajlm-2268	267	2	2016;6(may):1–11	CARDINAL
ajlm-2268	268	1	masika mm	PERSON
ajlm-2268	268	2	lule gn	PERSON
ajlm-2268	268	3	east african	NORP
ajlm-2268	269	1	plos	PERSON
ajlm-2268	269	2	one	CARDINAL
ajlm-2268	270	1	2019;14(2):1–12	CARDINAL
ajlm-2268	271	1	kiyimba k	PERSON
ajlm-2268	272	1	two	CARDINAL
ajlm-2268	272	2	eastern uganda	ORG
ajlm-2268	273	1	j glob	PERSON
ajlm-2268	275	1	szabo d. mechanisms	PERSON
ajlm-2268	276	1	clin infect dis	ORG
ajlm-2268	277	1	2006;43(suppl.	CARDINAL
ajlm-2268	278	1	2):49–56	CARDINAL
ajlm-2268	280	1	ethiopian	NORP
ajlm-2268	283	1	håkonsen h	ORG
ajlm-2268	283	2	toverud el	GPE
ajlm-2268	284	1	ethiopia	GPE
ajlm-2268	285	1	bmc health serv res	ORG
ajlm-2268	286	1	2018;18(1):1–7	CARDINAL
ajlm-2268	287	1	dona	ORG
ajlm-2268	287	2	a.	PERSON
ajlm-2268	287	3	yirgalem	GPE
ajlm-2268	287	4	sidama regional state	ORG
ajlm-2268	287	5	ethiopia	GPE
ajlm-2268	288	1	2021;9:205031212110424	CARDINAL
ajlm-2268	289	1	ali s	PERSON
ajlm-2268	289	2	suleman s.	PERSON
ajlm-2268	289	3	ethiopia	GPE
ajlm-2268	289	4	norway	GPE
ajlm-2268	290	1	plos one	PERSON
ajlm-2268	291	1	2021;16(5	CARDINAL
ajlm-2268	292	1	https://doi.org/10.1371/journal.pone.0251400 zanichelli v	PERSON
ajlm-2268	292	2	swiss	NORP
ajlm-2268	293	1	proteus mirabilis	ORG
ajlm-2268	293	2	switzerland	GPE
ajlm-2268	293	3	8-year	DATE
ajlm-2268	293	4	2009–2016	CARDINAL
ajlm-2268	295	1	2019;149(july):w20110	CARDINAL